Maternal exposure to per- and polyfluoroalkyl substances and epitope level antibody response to vaccines against measles and rubella in children from the Boston birth cohort
- PMID: 40215916
- PMCID: PMC12038861
- DOI: 10.1016/j.envint.2025.109433
Maternal exposure to per- and polyfluoroalkyl substances and epitope level antibody response to vaccines against measles and rubella in children from the Boston birth cohort
Abstract
Background: Previous studies suggest that per- and polyfluoroalkyl substances (PFAS) may act as immune suppressants. However, research about the impact of PFAS exposure on antibody responses to the measles, mumps, rubella (MMR) vaccine is limited and inconsistent.
Methods: This report includes 748 mother-child pairs from the Boston Birth Cohort, with 8 PFAS compounds measured in maternal plasma shortly after delivery. IgG reactivities to measles and rubella were profiled in cord blood and venous blood plasma during early childhood, using Phage ImmunoPrecipitation Sequencing. Linear regression models were applied to assess the relationships between log2-transformed PFAS and IgG reactivities as measured by Viral Aggregate Reactivity score (VARscore, with inverse normal transformation) for measles and rubella. Quantile g-computation was applied to evaluate the PFAS mixture - VARscore associations.
Results: The detection rate for 8 PFAS compounds ranged from 90 % to 100 % in maternal plasma. Maternal PFAS burden score (P = 0.01), but not individual PFAS compounds, was associated with lower VARscore for measles in cord blood. In 348 children after receiving the MMR vaccine, three maternal PFAS compounds (Me-PFOSA-AcOH, PFHpS and PFHxS) were significantly associated with lower measles VARscore (P < 0.05). Me-PFOSA-AcOH and PFHxS were significantly associated with higher risk of having low reactivity to measles defined as VARscore < 25th percentile. PFAS mixture analysis revealed a significant inverse association between quantile of the PFAS mixture and measles VARscore (P = 0.025) in children after vaccination, with PFHxS as an important contributor to this association. These inverse associations were more pronounced in Black children (compared to non-Black children) and in preterm children (compared to term children). In comparison, no associations were found for rubella VARscore.
Conclusions: This prospective birth cohort study provides suggestive evidence that maternal PFAS exposure is associated with a reduced immune response to the measles vaccine, especially, among Black or preterm children.
Keywords: Effect modifier; Immune Response; Measles; Per- and polyfluoroalkyl substances; PhIP-Seq; Vaccination.
Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [H.B.L. is a founder of Infinity Bio, a provider of antibody reactome profiling services. All other authors have no conflicts to disclose].
Figures





Similar articles
-
Associations of early life per- and polyfluoroalkyl substances (PFAS) exposure with body mass index and risk of overweight or obesity at age 2-18 years: Mixture analysis in the prospective Boston Birth Cohort.Environ Int. 2025 Jan;195:109206. doi: 10.1016/j.envint.2024.109206. Epub 2024 Dec 15. Environ Int. 2025. PMID: 39705976 Free PMC article.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD004407. doi: 10.1002/14651858.CD004407.pub5. Cochrane Database Syst Rev. 2021. PMID: 34806766 Free PMC article.
-
Prenatal Exposure to Poly- and Perfluoroalkyl Substances (2009-2014) and Vaccine Antibody Titers of Measles, Mumps, Rubella, and Varicella in Children Four to Eight Years Old from the Healthy Start Cohort.Environ Health Perspect. 2023 Dec;131(12):127018. doi: 10.1289/EHP12863. Epub 2023 Dec 26. Environ Health Perspect. 2023. PMID: 38147368 Free PMC article.
-
Vaccines for measles, mumps and rubella in children.Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD004407. doi: 10.1002/14651858.CD004407.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2020 Apr 20;4:CD004407. doi: 10.1002/14651858.CD004407.pub4. PMID: 22336803 Free PMC article. Updated.
-
A Prospective Analysis of Per- and Polyfluoroalkyl Substances from Early Pregnancy to Delivery in the Atlanta African American Maternal-Child Cohort.Environ Health Perspect. 2024 Nov;132(11):117001. doi: 10.1289/EHP14334. Epub 2024 Nov 6. Environ Health Perspect. 2024. PMID: 39504273 Free PMC article.
Cited by
-
Importance of post-translational protein modifications in PFAS toxicity.Toxicology. 2025 Aug 8;518:154260. doi: 10.1016/j.tox.2025.154260. Online ahead of print. Toxicology. 2025. PMID: 40784597 Review.
References
-
- Abraham K, Mielke H, Fromme H, Volkel W, Menzel J, Peiser M, Zepp F, Willich SN, Weikert C, 2020. Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response. Arch Toxicol 94, 2131–2147. - PMC - PubMed
-
- Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B, Marinovich M, Galli CL, Dell’Agli M, Germolec DR, 2012. In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol Appl Pharmacol 258, 248–255. - PubMed
-
- Crawford L, Halperin SA, Dzierlenga MW, Skidmore B, Linakis MW, Nakagawa S, Longnecker MP, 2023. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances. Environ Int 172, 107734. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous